GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Net Income From Continuing Operations

ABION (XKRX:203400) Net Income From Continuing Operations : ₩-27,440 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is ABION Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. ABION's net income from continuing operations for the three months ended in Mar. 2024 was ₩-7,310 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-27,440 Mil.

ABION Net Income From Continuing Operations Historical Data

The historical data trend for ABION's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABION Net Income From Continuing Operations Chart

ABION Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only -14,209.82 -10,475.68 -54,259.06 -19,925.39 -29,210.91

ABION Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9,080.48 -1,028.20 -10,785.01 -8,317.23 -7,309.74

ABION Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-27,440 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABION (XKRX:203400) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:166480 XKRX:234690 XKRX:348080 XKRX:353810 XKRX:365270 XKRX:389030 XKRX:067370 XKRX:251120 XKRX:065660 XKRX:261780 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
9th FI, HanWha Biz Metro Building, 242 Digital-ro, Guro-gu, Seoul, KOR, 08394
Website
http://www.abionbio.com
ABION Inc is a biopharmaceutical company. It is primarily involved in the research and development new bio pharmaceutical drugs and companion diagnostics systems for the treatment of incurable diseases.

ABION (XKRX:203400) Headlines

No Headlines